Filip Borgions
Chief Tech/Sci/R&D Officer en ARGENX SE .
Perfil
Filip Borgions is currently the Global Head-Technical Operations at argenx SE since 2015.
Previously, he worked as a Principal at Thrombogenics, Inc. Dr. Borgions has an undergraduate and doctorate degree from Katholieke Universiteit Leuven.
Cargos activos de Filip Borgions
| Empresas | Cargo | Inicio |
|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Antiguos cargos conocidos de Filip Borgions.
| Empresas | Cargo | Fin |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Formación de Filip Borgions.
| Katholieke Universiteit Leuven | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Empresas privadas | 1 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Filip Borgions
